Arthritis Drug Cuts GVHD Risk in Stem Cell Transplants

(MedPage Today) -- A widely used arthritis drug reduced the rate of acute graft-versus-host disease (GVHD) in both HLA-matched and -mismatched allogeneic stem-cell transplants, a randomized study showed.
The incidence of grade 3/4 acute GVHD after...